SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-15-112799
Filing Date
2015-03-31
Accepted
2015-03-31 06:06:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d899083d8k.htm SC TO-C 36953
2 EX-2.1 d899083dex21.htm EX-2.1 556161
3 EX-2.2 d899083dex22.htm EX-2.2 56360
4 EX-99.1 d899083dex991.htm EX-99.1 193096
  Complete submission text file 0001193125-15-112799.txt   844260
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Subject) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-86934 | Film No.: 15736335
SIC: 2834 Pharmaceutical Preparations

Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Filed by) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations